4//SEC Filing
Shah Preetam 4
Accession 0001610618-22-000029
CIK 0001610618other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:21 PM ET
Size
10.2 KB
Accession
0001610618-22-000029
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Award
Common Stock
2022-03-31+51,250→ 71,250 total - Tax Payment
Common Stock
2022-03-31$0.83/sh−24,820$20,601→ 112,431 total - Award
Employee Stock Option (right to buy)
2022-03-31+102,500→ 102,500 totalExercise: $0.83Exp: 2032-03-30→ Common Stock (102,500 underlying) - Award
Common Stock
2022-03-31+66,001→ 137,251 total
Footnotes (4)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
- [F2]Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date.
- [F3]Shares withheld for taxes on RSU vesting.
- [F4]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001787403
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 5:21 PM ET
- Size
- 10.2 KB